Ken Fujise

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 6

Top Topics

Antiplatelet Therapy

Endoplasmic Reticulum

Top Venues

Cell death discovery

Circulation research

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Srikruthi S Krishnachaitanya, Max Liu, Ken Fujise, Qingjie Li
MicroRNAs in Inflammatory Bowel Disease and Its Complications. International journal of molecular sciences 23 (15) (2022)
Decha Pinkaew, Erik Martinez-Hackert, Wei Jia, Matthew D King, Fei Miao, Nicole R Enger, Runglawan Silakit, Kota Ramana, Shi-You Chen, Ken Fujise
Fortilin interacts with TGF-β1 and prevents TGF-β receptor activation. Communications biology 5 (1) (2022)
Dunpeng Cai, Chenming Sun, Gui Zhang, Xingyi Que, Ken Fujise, Neal L Weintraub, Shi-You Chen
A Novel Mechanism Underlying Inflammatory Smooth Muscle Phenotype in Abdominal Aortic Aneurysm. Circulation research 129 (10) (2021)
Preedakorn Chunhacha, Decha Pinkaew, Patuma Sinthujaroen, Dawn E Bowles, Ken Fujise
Fortilin inhibits p53, halts cardiomyocyte apoptosis, and protects the heart against heart failure. Cell death discovery 7 (1) (2021)
Hasseri Halim, Decha Pinkaew, Preedakorn Chunhacha, Patuma Sinthujaroen, Perumal Thiagarajan, Ken Fujise
Ticagrelor induces paraoxonase-1 (PON1) and better protects hypercholesterolemic mice against atherosclerosis compared to clopidogrel. PloS one 14 (6) (2019)
Decha Pinkaew, Abhijnan Chattopadhyay, Matthew D King, Preedakorn Chunhacha, Zhihe Liu, Heather L Stevenson, Yanjie Chen, Patuma Sinthujaroen, Owen M McDougal, Ken Fujise
Fortilin binds IRE1α and prevents ER stress from signaling apoptotic cell death. Nature communications 8 (1) (2017)